Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. is making strides in the global healthcare market with its innovative Steriwave nasal decolonization technology, now being adopted by major NHS Trusts in the UK and top hospitals in Canada. The company has partnered with Mölnlycke Health Care to expand its reach across Europe and the Middle East. This development positions Ondine as a key player in addressing healthcare-associated infections and antibiotic resistance.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
